BMRN vs FIVE · P/E 40, rev $2.85B vs P/E 28, rev $1.39B
Biomarin Pharmaceutical Inc (BMRN) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the BMRN and FIVE stock pages for the full models.
Not investment advice.